{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:46:36Z","timestamp":1794473196555,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ahjo.2026.100781","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:58:45Z","timestamp":1775721525000},"page":"100781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adjunctive Eptifibatide Administration in ACS Patients Undergoing Percutaneous Coronary Intervention: A Randomized Comparison of Bolus-only Versus Standard Therapy"],"prefix":"10.1016","volume":"65","author":[{"given":"Fatemeh","family":"Baharvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Dadras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asieh","family":"Ashouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mirrazeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Aris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Jenab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ahjo.2026.100781_bb0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"Jama"},{"issue":"10332","key":"10.1016\/j.ahjo.2026.100781_bb0010","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","article-title":"Acute coronary syndromes","volume":"399","author":"Bergmark","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100781_bb0015","article-title":"Efficacy, safety, and role of antiplatelet drugs in the management of acute coronary syndrome: a comprehensive review of literature","volume":"15","author":"Abubakar","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100781_bb0020","first-page":"697","article-title":"Intracoronary bolus of glycoprotein IIb\/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction","volume":"70","author":"Galli","year":"2022","journal-title":"Minerva Cardiol. Angiol."},{"key":"10.1016\/j.ahjo.2026.100781_bb0025","first-page":"332","article-title":"Intracoronary versus intravenous administration of eptifibatide during percutaneous coronary intervention in patients with acute coronary syndromes","author":"Dashtabi","year":"2020","journal-title":"Acta Med. Iran."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100781_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ehjcvp\/pvae024","article-title":"Safety and effectiveness of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study","volume":"10","author":"Bruno","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"13","key":"10.1016\/j.ahjo.2026.100781_bb0035","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100781_bb0040","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"38","key":"10.1016\/j.ahjo.2026.100781_bb0045","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100781_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.14740\/cr675w","article-title":"Eptifibatide bolus dose during elective percutaneous coronary intervention","volume":"9","author":"Doustkami","year":"2018","journal-title":"Cardiol. Res."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100781_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","author":"World Medical A","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100781_bb0060","first-page":"55","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"13","author":"Byrne","year":"2024","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100781_bb0065","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ahjo.2026.100781_bb0070","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ahjo.2026.100781_bb0075","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahjo.2026.100781_bb0080","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/europace\/euac020","volume":"24","author":"Gorog","year":"2022","journal-title":"EP Europace"},{"issue":"9063","key":"10.1016\/j.ahjo.2026.100781_bb0085","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","article-title":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to minimise platelet aggregation and coronary thrombosis-II","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ahjo.2026.100781_bb0090","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1001\/jama.285.19.2468","article-title":"Platelet glycoprotein IIb\/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial","volume":"285","author":"O\u2019Shea","year":"2001","journal-title":"Jama"},{"issue":"20","key":"10.1016\/j.ahjo.2026.100781_bb0095","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ahjo.2026.100781_bb0100","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100781_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ahj.2008.04.019","article-title":"Bolus-only versus bolus + infusion of glycoprotein IIb\/IIIa inhibitors during percutaneous coronary intervention","volume":"156","author":"Kini","year":"2008","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100781_bb0110","first-page":"487","article-title":"High-dose, single-bolus eptifibatide: a safe and cost-effective alternative to conventional glycoprotein IIb\/IIIa inhibitor use for elective coronary interventions","volume":"18","author":"Fischell","year":"2006","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ahjo.2026.100781_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2023.01.023","article-title":"A double-blinded randomized controlled trial comparing eptifibatide bolus only versus bolus plus infusion in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"51","author":"Mousavi","year":"2023","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100781_bb0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCULATIONAHA.109.882746","volume":"121","author":"Deibele","year":"2010","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ahjo.2026.100781_bb0125","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:31:11Z","timestamp":1777606271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"alternative-id":["S2666602226000698"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100781","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive Eptifibatide Administration in ACS Patients Undergoing Percutaneous Coronary Intervention: A Randomized Comparison of Bolus-only Versus Standard Therapy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100781"}}